Filing Details
- Accession Number:
- 0001628280-24-045334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-05 16:40:20
- Reporting Period:
- 2024-10-01
- Accepted Time:
- 2024-11-05 16:40:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 1600 West End Avenue Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-10-01 | 31 | $1.27 | 28,335 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-02 | 31 | $1.29 | 28,366 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-03 | 31 | $1.28 | 28,397 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-04 | 31 | $1.28 | 28,428 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-07 | 31 | $1.29 | 28,459 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-08 | 31 | $1.30 | 28,490 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-09 | 31 | $1.31 | 28,521 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-10 | 31 | $1.32 | 28,552 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-11 | 31 | $1.39 | 28,583 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-14 | 31 | $1.37 | 28,614 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-15 | 31 | $1.30 | 28,645 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-16 | 31 | $1.25 | 28,676 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-17 | 31 | $1.30 | 28,707 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-18 | 31 | $1.28 | 28,738 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-21 | 31 | $1.25 | 28,769 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-22 | 31 | $1.25 | 28,800 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-23 | 31 | $1.26 | 28,831 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-24 | 31 | $1.24 | 28,862 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-25 | 31 | $1.23 | 28,893 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-28 | 31 | $1.25 | 28,924 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-29 | 31 | $1.24 | 28,955 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-30 | 31 | $1.32 | 28,986 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-10-31 | 31 | $1.20 | 29,017 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.